Current guidelines recommend that children with acute pyelonephritis are initially treated with a parenteral third-generation cephalosporin such as ceftriaxone, and then oral antibiotics.

The FDA is recommending an additional clinical trial to confirm glepaglutide’s efficacy and safety at the to-be-marketed dose.

The U.S. Food and Drug Administration has declined to approve Zealand Pharma's bowel disease drug and sought an additional ...

Daniel J. Trisno [Opens in a new window], This study characterized outpatient parenteral antimicrobial therapy (OPAT) orders and associated antimicrobial stewardship program (ASP) pharmacist ...

Copenhagen, Denmark Monday, December 23, 2024, 12:00 Hrs [IST] ...

Purpose: The technical issues surrounding the use of albumin in parenteral nutrient (PN) solutions are reviewed. Summary: Five criteria have been suggested to determine which compounds are optimal ...

A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the product to be used. It includes aspects such as pH range, osmolality and API ...

Zealand Pharma (ZLDPF) announced that the U.S. Food and Drug Administration has issued a Complete Response Letter for the company’s New Drug ...